주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 22:07
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Korean Drug Ministry Bans Sales of Kolon’s Degenerative Arthritis Treatment Invossa-K
Choi Moon-hee
2019.04.01 12:46
Kolon Life Sciences Obtain FDA’s Approval for Clinical Trials of Neuropathic Pain Treatment
Choi Moon-hee
2019.03.12 09:15
Foreign Companies Listed on S. Korean Stock Market Show Poor Performance
Michael Herh
2019.02.15 11:34
Industries
Kolon to Export Invossa Osteoarthritis Therapy to Nine Countries
Choi Moon-hee
2019.01.15 11:59
Kolon Life Science Licenses out Invossa-K to Mundipharma for 667.7 Bil. Won
Choi Moon-hee
2018.11.19 15:20
Korea's Kolon Group Seeking to Boost Competitiveness in Pharmaceutical and Biotech Businesses
Choi Mun-hee
2018.08.21 12:20
Kolon to Export 230 Bil. Won Worth of Invossa to China
Choi Mun-hee
2018.07.19 11:31
Invossa Authorized to Enter Phase 3 Clinical Trial in US
Choi Mun-hee
2018.07.09 15:44
Kolon to Export Invossa to Hong Kong, Macao and Mongolia
Choi Mun-hee
2018.06.21 14:09
Kolon Confident of Gaining US FDA Approval for Invossa
Choi Mun-hee
2018.06.07 14:22
Kolon Group Paves Way for Invossa Export to Middle East
Choi Mun-hee
2018.05.04 12:23
Stock Market Experts Warn Biotech Bubble Will Burst Soon
Choi Mun-hee
2018.04.19 09:54
처음
이전
이전
1
2
3
4
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기